CRA provided an expert opinion on damages in a breach of contract arbitration concerning certain work performed by a subcontractor during the development of a vaccine candidate. CRA quantified the plaintiff’s lost investment and its losses attributable the diminution in value of the vaccine candidate due to delayed clinical development and approval. Dr. Sean Sheridan provided a report on economic damages as well as deposition and hearing testimony.
Richard Bergin joins CRA's Finance Practice as Vice President
CRA is pleased to announce that Richard Bergin has joined the company’s Finance Practice as a vice president. “We are very pleased to welcome Richard to CRA,”...